Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...

BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

While there is currently no cure for Parkinson’s disease, early diagnosis and ongoing care can significantly improve quality of life and alleviate symptoms ...

The RCBC Travel Fair 2025 is happening at the Shangri-La Plaza Mall Grand Atrium from April 10 to 13, 2025, bringing together ...

Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.

Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season. The medical devices ...